BIO-TECHNE Corp Proceeds from Long-Term Debt Issued
BIO-TECHNE Corp (TECH) reported Proceeds from Long-Term Debt Issued of $0 for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-05-07
- BIO-TECHNE Corp proceeds from issuance of long-term debt for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- BIO-TECHNE Corp proceeds from issuance of long-term debt for the quarter ending 2020-03-31 was $40.00M.
- BIO-TECHNE Corp proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was $580.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month |
|---|---|---|---|
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $0.00 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-08 | ||
| 2020-03-31 | $40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $40.00M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-08 | ||
| 2018-09-30 | $580.00M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |